drugset
Drugs / Vivaxin
last change Mar 2026 re-read 3 minutes ago

Vivaxin

Vaccine

Developed for
Plasmodium vivax malaria
Investigated by
CT Vacinas - Centro de Tecnologia em Vacinas/Universidade Federal de Minas Gerais · Federal University of Minas Gerais · Financiadora de Estudos e Projetos · INCTV National Institute of Vaccine Science and Technology · São Paulo Research Foundation · The Ministry of Science, Technology and Innovation, Brazil
+1 more · University of Sao Paulo

Trials 1

today NCT07172724 · Ph 1
2026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07172724 Sep 2025 → Mar 2026 overdue Plasmodium vivax malaria Federal University of Minas Gerais Not yet recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vivaxin ClinicalTrials.gov intervention name — accepted as the source's own label NCT07172724 ↗
Modality Vaccine “a malaria vaccine named Vivaxin” NCT07172724 ↗
Route Intramuscular “following intramuscular administration of three doses of 0.3 mL/dose” NCT07172724 ↗